Trial · NCT04592419
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Primary Study (Through Year 1) | STARTED | KSI-301 (Arm A) | 284 | |
| Primary Study (Through Year 1) | STARTED | Aflibercept (Arm B) | 284 | |
| Primary Study (Through Year 1) | Completed Treatment at Week 20 | KSI-301 (Arm A) | 270 | |
| Primary Study (Through Year 1) | Completed Treatment at Week 20 | Aflibercept (Arm B) | 274 | |
| Primary Study (Through Year 1) | Did Not Discontinue Treatment Before Week 24 | KSI-301 (Arm A) | 270 | |
| Primary Study (Through Year 1) | Did Not Discontinue Treatment Before Week 24 | Aflibercept (Arm B) | 276 | |
| Primary Study (Through Year 1) | Did Not Discontinue Study Before Week 24 | KSI-301 (Arm A) | 275 | |
| Primary Study (Through Year 1) | Did Not Discontinue Study Before Week 24 | Aflibercept (Arm B) | 276 | |
| Primary Study (Through Year 1) | COMPLETED | KSI-301 (Arm A) | 255 | |
| Primary Study (Through Year 1) | COMPLETED | Aflibercept (Arm B) | 255 | |
| Primary Study (Through Year 1) | NOT COMPLETED | KSI-301 (Arm A) | 29 | |
| Primary Study (Through Year 1) | NOT COMPLETED | Aflibercept (Arm B) | 29 | |
| Open-Label Extension Period | STARTED | KSI-301 (Arm A) | 216 | |
| Open-Label Extension Period | STARTED | Aflibercept (Arm B) | 228 | |
| Open-Label Extension Period | COMPLETED | KSI-301 (Arm A) | 135 | |
| Open-Label Extension Period | COMPLETED | Aflibercept (Arm B) | 130 | |
| Open-Label Extension Period | NOT COMPLETED | KSI-301 (Arm A) | 81 | |
| Open-Label Extension Period | NOT COMPLETED | Aflibercept (Arm B) | 98 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04592419/flow